Sibylla Biotech

Homepage

Business Model
B2B
Total Funding
$22.6M
Last Round
$22.6M Series AOct 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sibylla Biotech develops small-molecule protein degraders by targeting proteins while they are still folding, using its PPI-FIT technology and Oneiros AI platform. The company combines computational protein-folding simulations with medicinal chemistry to advance internal drug-discovery programs and pharmaceutical partnerships, including published validation work on the prion protein. Its approach grew out of academic research at the University of Trento and is designed to characterize folding pathways of biologically relevant proteins at atomic resolution.

Summary

Sibylla Biotech is an Artificial Intelligence company. It has raised $22.6M in total across 1 round, most recently a $22.6M Series A round in Oct 2022. Investors include V-Bio Ventures, CDP Venture Capital SGR and Claris Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2022
$22.6M

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sibylla Biotech on Indexed.vc
<a href="https://indexed.vc/companies/sibylla-biotech"><img src="https://indexed.vc/api/badge/company/sibylla-biotech" alt="Sibylla Biotech on Indexed.vc" width="260" height="76" /></a>